Search

The National Institutes of Health's National Center for Advancing Translational Sciences (NCATS) and the National Institute of Allergy and Infectious Diseases (NIAID) are hosting a joint workshop on bacteriophage therapy on October 25, 2022

The National Institute of Allergy and Infectious Diseases (NIAID) has begun a clinical trial for phage therapy in adults with cystic fibrosis, under the leadership of IPATH. The trial plans to enroll 72 participants across 16 cystic fibrosi

Phagos, a French phage manufacturing company, announced the closing of a €2.4 million Seed investment round co-led by Demeter (Paris) and Hoxton Ventures (London).

Adaptive Phage Therapeutics (APT) has announced that the Defense Health Agency (DHA) has awarded an additional $5 million to support clinical development of APT’s adaptive bacteriophage therapy in treatment of diabetic foot osteomyelitis (D

SpyPhage: A Cell-Free TXTL Platform for Rapid Engineering of Targeted Phage Therapies, by Sahan B. W. Liyanagedera and colleagues, proposes the SpyPhage system where a “scaffold” bacteriophage is engineered to incorporate a SpyTag moiety on

In this Nature Communications paper, Brieuc Van Nieuwenhuyse (Université Catholique de Louvain) and colleagues report the story of a toddler who suffered from extensively drug-resistant Pseudomonas aeruginosa sepsis after liver transplantat

In a new paper in Molecular Ecology, Tue Kjærgaard Nielsen (University of Copenhagen) and colleagues review current approaches to detect nucleotide modifications, including hardware and software, and look onward to future applications, espe

Paweł Działak (AGH University of Science and Technology) and colleagues published a new paper in the journal Biogeosciences entitled Do bacterial viruses affect framboid-like mineral formation?

Bennett J. Davenport et al. published a new paper in npj Vaccines entitled Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease.

In a new paper in International Journal of Food Microbiology, Amel Chaïb (University of Bordeaux) and colleagues review the current knowledge about bacteriophages of Oenococcus oeni and their possible impacts on the trajectory of the microb

In this Nature Microbiology paper, Christopher N. Vassallo and colleagues used an experimental selection scheme agnostic to genomic context to identify phage defence systems in 71 diverse E. coli strains. They found 21 conserved defence sys

Genome Startup Day Fall 2022: Bacteria Breakthroughs is a virtual event on October 5th, 2:00-3:00 pm PST that will feature a fireside chat with John Eisen, PhD, UC Davis professor and renowned genomics and microbiology researcher, and Ivan

News: Locus Biosciences announces first patient treated in the ELIMINATE phase 2/3 trial for urinary tract infections.

Paper: Cell-free production of personalized therapeutic phages targeting multidrug-resistant bacteria

Review: Determination of phage susceptibility as a clinical diagnostic tool: A routine perspective

Paper: AcaFinder: genome mining for anti-CRISPR associated genes

Paper: The M13 phage assembly machine has a membrane-spanning oligomeric ring structure.

Adaptive Phage Therapeutics announces "The AMR RAPID™ Challenge": APT will pay $1000 to to any individual or institution in the clinical research community who can find a bacteria resistant to their investigational Phage Bank.

Paper: MetaPhage: an automated pipeline for analyzing, annotating, and classifying bacteriophages in metagenomics sequencing data.

Paper: Isolation and characterization of Brochothrix phage ADU4.